• Skip to main content
  • Skip to header right navigation
  • Skip to site footer
IMCS

IMCS

A leader in recombinant enzymes and automated micro-chromatography technologies

  • ABOUT
    • ABOUT IMCS
    • QUALITY POLICY
    • RESEARCH AT IMCS
    • CAREERS
  • PRODUCTS
    • IMCSzyme®
      • IMCSzyme E1F
      • IMCSzyme RT
      • IMCSzyme® CATALOG
    • IMCStips®
      • APPLICATIONS
        • AFFINITY
        • SIZE EXCLUSION
        • NUCLEIC ACIDS
        • ION EXCHANGE
        • REVERSE PHASE
        • PHOSPHOPEPTIDE
      • IMCStips® CATALOG
      • AUTOMATION PLATFORMS
        • DYNAMIC DEVICES
        • HAMILTON
        • INTEGRA
        • TECAN
        • OPENTRONS
        • ANALYTIK JENA
    • SULFATASES
      • Sulfazyme
      • Sulfazyme™ DS
      • Sulfazyme™ β-AS
    • GLYCO REAGENTS
      • GLYCOLIPIDS
      • ACTIVATED SUGARS
      • BIOSYNTHETIC ENZYMES
      • SMALL MOLECULES
    • SPHINGOSINES
    • OTHER PROTEINS
      • PURIFIED STREPTAVIDIN
      • B. pi. β-glucuronidase variant
  • SERVICES
    • BETA-GLUCURONIDASES & SULFATASES
      • β-GLUCURONIDASE VALIDATION SERVICES
      • HIGH-THROUGHPUT TOXICOLOGY WORKFLOWS
    • IMCStips®
      • SAMPLE PREPARATION AUTOMATION
      • HIGH-THROUGHPUT METHOD DEVELOPMENT
      • AUTOMATION PLATFORMS
        • DYNAMIC DEVICES
        • HAMILTON
        • INTEGRA
        • TECAN
        • OPENTRONS
        • ANALYTIK JENA
    • OTHER SERVICES
      • GLYCAN PRODUCTION (Coming Soon)
      • R&D COLLABORATIONS
      • EXTRACELLULAR VESICLES
  • RESOURCES
    • FAQ
    • IMCSZYME RESOURCES
    • IMCSTIPS RESOURCES
    • SAFETY DATA SHEETS
    • CERTIFICATE OF ANALYSIS
  • LATEST NEWS
    • LATEST NEWS
    • PODCAST
    • BLOG
    • EVENTS
    • WEBINARS
  • SHOP
  • CONTACT
  • en
    • en
    • es
    • fr
    • de
    • zh-CN

Maximizing Yield from Nucleic Acid Extraction/Purification: A Troubleshooting Guide

December 18, 2023

Nucleic acid extraction or purification is crucial in various molecular biology experiments. Several methods are available for nucleic acid extraction or purification, including phenol-chloroform extraction, spin column extraction, and magnetic bead purification. Here are some problems and solutions to maximize yield from these methods:

Table of Contents
    Add a header to begin generating the table of contents

    PHENOL-CHLOROFORM EXTRACTION

    Problem 1: Incomplete homogenization

    Incomplete homogenization can occur when the sample is not ground to a fine powder or when a tissue homogenizer is not used to disrupt the cells properly. As a result, the nucleic acids may not be released from the cells effectively, leading to low yield.

    If grinding the tissue to a fine powder, it's essential to avoid over-drying the tissue, as this can result in DNA degradation. Similarly, when using a tissue homogenizer, selecting the appropriate speed and duration is important to ensure efficient cell disruption. Proper homogenization guarantees the effective release of nucleic acids from the cells. Lysis buffers and sonication can also aid in further breaking down the cells and releasing nucleic acids from the sample.

    Problem 2: Poor phase separation

    Poor phase separation during phenol-chloroform extraction can lead to the loss of nucleic acids. This can occur when the sample is not mixed properly with phenol and chloroform or when the centrifugation speed or duration is not appropriate. As a result, the nucleic acids may remain in the wrong phase or may not be extracted efficiently, leading to low yield.

    It is important to ensure that the sample is mixed properly with phenol and chloroform and that the centrifugation speed and duration are appropriate. The sample should be mixed gently but thoroughly with phenol and chloroform to ensure that the nucleic acids are extracted efficiently. Additionally, the centrifugation speed and duration should be optimized to ensure proper phase separation. If the sample is not centrifuged for a sufficient duration, the phases may not separate effectively, leading to low yield. On the other hand, if the centrifugation speed is too high, the nucleic acids may be lost to the organic phase, leading to low yield as well.

    Problem 3: DNA or RNA degradation

    DNA or RNA degradation can occur due to the presence of nucleases, which are enzymes that degrade nucleic acids. This can occur during the extraction process or during storage of the samples. As a result, the yield of nucleic acids may be low or the quality may be poor.

    It is crucial to use nuclease-free solutions and equipment and to handle the samples with care to avoid the introduction of nucleases into the sample. Excessive shaking or vortexing should be avoided as it can cause mechanical shearing of DNA or RNA. And to prevent RNA degradation during the extraction process, RNase inhibitors can be added.

    Problem 4: Protein contamination

    Protein contamination can occur when the proteins are not removed from the sample effectively during the extraction process.

    To address this problem, it is important to use proteinase K treatment or perform an additional chloroform extraction step to remove proteins. Proteinase K treatment can digest the proteins and remove them from the sample. Additionally, the use of phase-lock gel tubes or phase-prep tubes can help to remove proteins. These tubes contain a gel that can selectively bind proteins, allowing the nucleic acids to be recovered in the aqueous phase. Finally, an additional chloroform extraction can be performed to remove any remaining proteins. The aqueous phase can then be collected for further nucleic acid purification. It is important to note that excessive protein removal can lead to lower yield, so it is important to optimize the protein removal step for each sample.

    Problem 5: pH instability

    pH instability can result in the loss of nucleic acids or the formation of precipitates during nucleic acid extraction using phenol-chloroform. This can occur when the pH of the sample is not maintained during the extraction process.

    It is important to select the appropriate buffer for the extraction and to monitor the pH of the sample during the extraction process. Tris-HCl or TE buffer is commonly used for nucleic acid extraction, as they have a buffering capacity that can maintain the pH of the sample. Additionally, it is important to use fresh buffers and to ensure that the pH of the buffer is checked and adjusted if necessary. pH paper or a pH meter can be used to monitor the pH of the sample during the extraction process. By maintaining the appropriate pH, the loss of nucleic acids or the formation of precipitates can be minimized.

    Problem 6: Low elution volume

    Low elution volume can result in a low yield of nucleic acids during phenol-chloroform extraction. This can occur when the elution buffer volume is not optimized for the amount of starting material or when the sample is not properly centrifuged to elute the nucleic acids.

    The elution buffer volume should be optimized based on the amount of starting material to ensure that the nucleic acids are properly eluted. Additionally, the sample should be centrifuged for a sufficient duration and at an appropriate speed to ensure that the nucleic acids are fully eluted from the column or tube. If necessary, the elution buffer can be preheated to increase the yield of nucleic acids.

    RELATED SOLUTIONS: NUCLEIC ACID PURIFICATION WITH IMCStips®
    IMCStips are pipette tip-based micro-chromatography columns that utilize patented dispersive solid-phase extraction (dSPE) technology to provide high-quality, high-throughput automated nucleic acid purification: from transfection-grade plasmid DNA for your minipreps to PCR cleanup. LEARN MORE

    SPIN COLUMN EXTRACTION

    Problem 1: Insufficient sample lysis

    One of the common problems in spin column-based nucleic acid extraction is insufficient sample lysis. Incomplete cell lysis can lead to lower yield due to the incomplete release of nucleic acids from cells or tissues. This can happen due to inadequate lysis buffer, suboptimal lysis conditions, or short incubation times. Insufficient lysis can also cause the release of nuclease enzymes from the cells, which can degrade the nucleic acids, leading to lower yield and poor quality of the extracted nucleic acids.

    It is important to ensure complete cell lysis. This can be achieved by using an appropriate lysis buffer, optimizing lysis conditions such as pH, temperature, and duration of incubation, and using longer incubation times. The use of detergents such as Triton X-100 or SDS in the lysis buffer can enhance cell lysis by disrupting the cell membrane. Additionally, the use of mechanical methods such as bead beating or sonication can help to break down the cells and enhance nucleic acid release. It is also essential to avoid overloading the spin column with too much sample, as this can lead to incomplete lysis.

    Problem 2: Inefficient binding

    Another problem that can affect the yield of nucleic acids obtained from spin column-based extraction is inefficient binding of nucleic acids to the spin column. This can happen due to inadequate mixing of the binding buffer and the sample, or due to the presence of contaminants that interfere with nucleic acid binding.

    To improve binding efficiency, it is important to ensure proper mixing of the sample and the binding buffer. The binding buffer should also have the appropriate pH and salt concentration for optimal nucleic acid binding. Pre-washing the column with the wash buffer can help to remove any contaminants that may interfere with binding. Additionally, the use of chaotropic salts such as guanidine or ammonium sulfate in the binding buffer can enhance nucleic acid binding. It is also essential to avoid overloading the spin column with too much sample, as this can lead to inefficient binding.

    Problem 3: Incomplete washing

    Incomplete washing is another problem that can result in low yield and poor quality of the extracted nucleic acids. Incomplete washing can result in residual impurities in the final eluate, leading to poor quality and lower yield of nucleic acids.

    To avoid incomplete washing, it is essential to perform the recommended number of washes with the appropriate wash buffer. The wash buffer should be added to the spin column in small volumes and allowed to flow through completely before adding the next wash buffer. It is also important to centrifuge the spin column for the recommended duration to ensure efficient washing. If residual impurities are still present in the eluate, additional washes may be necessary.

    Problem 4: Low elution volume

    Low elution volume can result in lower yield of nucleic acids. This can happen when the recommended elution buffer volume is not used, or elution is performed at suboptimal temperature or duration.

    To increase the elution volume, it is recommended to use a higher volume of elution buffer and to let the column incubate with the buffer for a few minutes before centrifugation. Additionally, warming the elution buffer to 60-70°C can help to improve the yield by reducing the viscosity of the buffer and promoting better flow through the column. It is important to note that using too much elution buffer can dilute the nucleic acid, so the recommended volume should be followed.

    MAGNETIC BEAD PURIFICATION

    Problem 1: Incomplete bead resuspension

    Incomplete resuspension of the magnetic beads can lead to uneven binding of nucleic acids and reduced yield. This can happen when the magnetic beads are not fully dispersed, resulting in clumps of beads that do not come into contact with the sample. This can result in lower yields of nucleic acids because there are fewer beads to bind to the nucleic acids.

    To ensure complete bead resuspension, it is recommended to gently vortex the beads until they are completely dispersed and homogenous. Incomplete bead resuspension can also be avoided by using pre-made bead solutions that do not require any further preparation. By properly resuspending the beads, the binding capacity of the beads is optimized, leading to higher yields of nucleic acids.

    Problem 2: Inadequate washing

    Inadequate washing of the magnetic beads can lead to the presence of contaminants, such as residual salts or detergents, which can inhibit downstream applications or interfere with yield. This can happen when the beads are not washed properly, leading to residual contaminants that interfere with the nucleic acid extraction or subsequent applications.

    Adequate washing of magnetic beads is necessary to remove residual contaminants that can interfere with downstream applications. Washing the beads thoroughly with buffer solutions and centrifugation can help to ensure complete removal of contaminants. By washing the beads properly, the purity of the nucleic acid sample is improved, leading to better yields and downstream applications.

    Problem 3: Over-drying of the beads

    Over-drying of the magnetic beads can cause the beads to clump together, reducing their surface area and hence, reducing their binding capacity. This can happen when the beads are allowed to dry too much, leading to clumping that reduces their surface area and hence their binding capacity.

    Over-drying can be avoided by drying the beads with a brief centrifugation and removing any excess liquid by pipetting, leaving the beads slightly damp. By avoiding over-drying, the binding capacity of the beads is optimized, leading to higher yields of nucleic acids.

    Problem 4: Incomplete elution

    Incomplete elution can result in a loss of nucleic acid yield and purity. This can happen when the elution buffer is not effective at releasing the nucleic acids from the beads or when the elution step is not carried out properly.

    Proper elution can be achieved by adding the appropriate elution buffer and incubating at the recommended temperature and time, followed by centrifugation. Repeating the elution step or increasing the elution volume can help to ensure complete elution. By optimizing the elution step, the yield and purity of the nucleic acid sample can be improved, leading to better downstream applications.

    Conclusion

    Obtaining optimal yields from nucleic acid extraction and purification requires careful consideration of several factors, including sample preparation, phase separation, and enzyme activity. This guide provides solutions to common challenges in phenol-chloroform extraction, spin column extraction, and magnetic bead purification. These solutions include homogenization, phase separation, DNA/RNA degradation, and protein contamination.

    Understanding the principles of each step and troubleshooting issues can improve the yields from nucleic acid extraction, leading to greater productivity in the lab. For labs with automation capabilities and high-throughput needs, however,  automated tip-based nucleic acid purification with IMCStips® is worth exploring. This high-throughput, automated technology uses dispersive solid-phase extraction and strong cation resins to deliver transfection-grade plasmid DNA, up to 96 samples in less than one hour. Fill out the form below to request a free sample, or visit our IMCStips Nucleic Acids page to learn more.

    Ready to get started? Contact us today for a free sample!

    Get Started
    Category: BLOG
    Previous Post:In-well hydrolysis at room temperature with IMCSzyme® RT and β-Gone™ Plus
    Next Post:Episode 0: IMCS Podcast Trailer

    Customize Your Workflow

    IMCS recognizes our customers’ needs vary, which is why we provide tailored tools and services to help you reach your laboratory’s goals.

    VIEW OUR CUSTOM SOLUTIONS

    ABOUT IMCS

    INTEGRATED MICRO-CHROMATOGRAPHY SYSTEMS, INC. (IMCS) IS A BIOTECHNOLOGY COMPANY FOCUSED ON DELIVERING TOOLS AND SERVICES THAT HELP PAVE THE WAY FOR THE FUTURE OF PRECISION MEDICINE. WE STRIVE TO ADDRESS THE GROWING NEEDS OF CLINICAL AND RESEARCH LABORATORIES THROUGH ADVANCED TECHNOLOGIES THAT INCREASE TESTING EFFICIENCY AND ACCURACY.

    STAY UP TO DATE

    WANT REGULAR UPDATES ON OUR INNOVATIVE PRODUCTS?
    Sign up to receive exclusive emails and offers from IMCS.
    !
    !
    !
    Subscribe
    Something went wrong. Please check your entries and try again.

    ABOUT

    ABOUT IMCS

    CAREERS

    QUALITY POLICY

    RESEARCH AT IMCS

    PRODUCTS

    IMCSZYME

    IMCSZYME RT

    IMCSTIPS

    PROTEINS, ENZYMES, RESINS

    GLYCO REAGENTS

    TERMS

    TERMS OF USE

    PRIVACY POLICY

    STANDARD TERMS AND CONDITIONS

    FCOI POLICY

    CONNECT WITH US

    IMCS, Inc. Headquarters
    110 Centrum Drive
    Irmo, SC 29063

    • IMCS LinkedIn Page
    • IMCS Facebook Page
    • IMCS Twitter Page

    COPYRIGHT © 2026 · IMCS · ALL RIGHTS RESERVED ·

    Return to top

    Get Started Today!

    Please fill out the form below to get started.

    "*" indicates required fields

    Step 1 of 3

    33%
    Which IMCStips applications you are interested in? Please select all that apply.*
    Name*
    Automated Liquid Handling System*
    Consent*

    Caleb-Schlachter-for-web

    Caleb R. Schlachter, Ph.D.

    Principal Scientist
    Caleb R. Schlachter, Ph.D., as the Principal Scientist at IMCS, leads and provides guidance for several research and development projects that involve proteins, including enzymes for glycan hydrolysis and glycan synthesis. He has co-authored multiple patents, posters, and peer-reviewed articles on β-glucuronidases and sulfatases.
    Gray Amick for web

    Gray D. Amick, Ph.D.

    Director of Operations
    Gray D. Amick, Ph.D., is the Director of Operations at IMCS with over 26 years of experience in forensic DNA analysis and toxicology. Prior to joining IMCS, he led forensic DNA testing for the Richland County Sheriff’s Department as technical leader and lab director. He has been court-qualified as an expert over 100 times and has authored and co-authored multiple posters and peer-reviewed articles.
    Amanda M Headshot

    Amanda C. McGee

    Research Scientist
    Amanda C. McGee is a Research Scientist at IMCS involved with enzyme characterizations, new analytical method developments, and advanced technical support. She joined IMCS with several years of experience in analytical testing for active pharmaceutical ingredients as per cGMP, USP and ICH guidelines. She has co-authored peer reviewed articles in the Journal of Analytical Toxicology and presented research at national and international conferences.
    Andrew_Headshot

    L. Andrew Lee, Ph.D.

    Co-Founder and Chief Scientific Officer
    L. Andrew Lee, Ph.D. co-founded IMCS and leads research and development efforts in enzyme engineering and automated micro-chromatography workflows. He directs new market efforts in glycan synthesis, supported by three NIH Fast-Track awards.

    Get started with 2N1 below

    "*" indicates required fields

    Name*
    Would you be interested in joining the 2N1 beta program?*
    Which product are you interested in? (select all that apply)*
    What are your current purification workflows? (select all that apply)*
    Please select your automation platform(s) (select all that apply)*
    How soon are you planning on evaluating 2N1?*
    Consent*

    DOWNLOAD OUR POSTERS

    "*" indicates required fields

    This field is for validation purposes and should be left unchanged.
    Please select the posters you would like to download*
    Name*
    Please provide a valid email so we can send you the download link.
    Location*
    Automated Liquid Handling System
    Contact preferences*
    Consent*

    Podcast Form

    "*" indicates required fields

    Name*
    How would you like to connect?*
    Please let us know what's on your mind. Have a question for us? Ask away.

    Ready for a change? Get your FREE sample of IMCSzyme® RT today.

    "*" indicates required fields

    This field is for validation purposes and should be left unchanged.
    Name*
    Consent*